<\/p>\n
Fullsize Paper<\/strong><\/p>\n <\/p>\n Review Paper<\/strong><\/p>\n <\/p>\n Teaching Paper<\/strong><\/p>\n <\/p>\n Abstracts<\/strong><\/p>\n <\/p>","protected":false},"excerpt":{"rendered":" Publication List<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":30428,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-full-width.php","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"class_list":["post-7990","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/7990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/comments?post=7990"}],"version-history":[{"count":1,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/7990\/revisions"}],"predecessor-version":[{"id":30461,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/7990\/revisions\/30461"}],"up":[{"embeddable":true,"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/pages\/30428"}],"wp:attachment":[{"href":"https:\/\/relaunch.iabnetz.com\/en\/wp-json\/wp\/v2\/media?parent=7990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\nMK (2011) Upregulation of microglial C1q expression has no effects on nigrostriatal
\ndopaminergic injury in the MPTP mouse model of Parkinson disease. J.
\nNeuroimmunol. 236:39-46.<\/li>\n
\n(2012) Combined elemental and biomolecular mass spectrometry imaging for probing
\nthe inventory of tissue at a micrometer scale. Anal. Chem. 84: 3170-3178.<\/li>\n
\nQuantitative imaging of Cu, Fe, Mn and Zn in the L-DOPA-treated unilateral 6-
\nhydroxydopamine Parkinson’s disease mouse model by LA-ICP-MS. Biomedical
\nSpectroscopy and Imaging 1: 125-136.<\/li>\n
\n(2013) Species-specific vesicular monoamine transporter 2 (VMAT2) expression
\ninmammalian pancreatic beta cells: implications for optimising radioligand-based
\nhuman beta cell mass (BCM) imaging in animal models. Diabetologia 56:1047-1056.<\/li>\n
\nSch\u00e4fer MK (2014) Transcriptional and structural plasticity of tyrosine hydroxylase
\nexpressing neurons in both striatum and nucleus accumbens following dopaminergic
\ndenervation. J. Chem. Neuroanatomy 61-62:169-175.<\/li>\n
\nDepboylu C (2015) Striatal tyrosine hydroxylase-positive neurons are associated with
\nL-DOPA induced dyskinesia in hemiparkinsonian mice. Neuroscience 298:302-17.<\/li>\n
\nDepboylu C (2016) L-DOPA-induced dyskinesia is associated with a deficient
\nnumerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons.
\nNeuroscience 331:120-133.<\/li>\n
\n(2018) Impaired Quality of Life and Need for Palliative Care in a German Cohort of
\nAdvanced Parkinson’s Disease Patients. Front Neurol. 2018 Mar 6;9:120. doi:
\n10.3389\/fneur.2018.00120.<\/li>\n
\nA, Wegner F. Calcium, Sodium, and Transient Receptor Potential Channel Expression
\nin Human Fetal Midbrain-Derived Neural Progenitor Cells. Stem Cells Dev. 2018 Jul
\n15;27(14):976-984.<\/li>\n
\nValidating the Parkinson\u2019s disease caregiver burden questionnaire (PDCB) in German
\ncaregiver of advanced Parkinson\u2019s disease patients. International Psychogeriatrics.
\n2019 Mar 25:1-10. doi: 10.1017\/S1041610219000206.<\/li>\n
\nPharmacotherapies for Parkinson\u2019s Disease in Geriatric Patients. Drugs and Aging.
\n2019 Apr 2. doi: 10.1007\/s40266-019-00654-z.<\/li>\n
\nhypersalivation in patients with amyotrophic lateral sclerosis: an open-label singlecentre study. J Neural Transm (Vienna). 2019 Oct;126(10):1341\u20135.<\/li>\n
\nSheriff S, Lanfermann H, Ding X. Altered Neurometabolic Profile in Early Parkinson’s
\nDisease: A Study With Short Echo-Time Whole Brain MR Spectroscopic Imaging.
\nFront Neurol. 2019 Jul 17;10:406\u201311.<\/li>\n
\nof German People with Parkinson\u2019s Disease Are Unspecific in regard to Typical
\nComplications. Parkinson’s Disease. Hindawi; 2019 Aug 4;2019:1\u20138.<\/li>\n
\nF, Dressler D. Caregiver burden and health-related quality of life in idiopathic dystonia
\npatients under botulinum toxin treatment: a cross-sectional study. J Neural Transm.
\nSpringer Vienna; 2020 Jan;127(1):61\u201370.<\/li>\n
\nSchenk T, Goetz CG, Stebbins GT, H\u00f6glinger GU. The Progressive Supranuclear Palsy
\nClinical Deficits Scale. Mov Disord. 2020 Apr;35(4):650\u201361.<\/li>\n
\nH\u00f6glinger GU, Wegner F. Mindfulness and Psychological Flexibility are Inversely
\nAssociated with Caregiver Burden in Parkinson\u2019s Disease. Brain Sciences.
\nMultidisciplinary Digital Publishing Institute; 2020 Feb;10(2):111\u201310.<\/li>\n
\nConsensus-Based Recommendations for Advance Directives of People with
\nParkinson\u2019s Disease in Regard to Typical Complications by German Movement
\nDisorder Specialists. JCM. Multidisciplinary Digital Publishing Institute; 2020
\nFeb;9(2):449\u201314.<\/li>\n
\nH\u00f6glinger GU, Wegner F. Association of Motor and Cognitive Symptoms with Health-
\nRelated Quality of Life and Caregiver Burden in a German Cohort of Advanced
\nParkinson\u2019s Disease Patients. Parkinson’s Disease. Hindawi; 2020 Feb 24;2020:1\u20138.<\/li>\n
\nC, Wegner F, Dressler D. Dysphagia in cervical dystonia patients receiving optimised
\nbotulinum toxin therapy: a single-center retrospective cohort study. J Neural Transm
\n(Vienna). 2020;127(8):1161-1165.<\/li>\n
\nGU, Wegner F. Alexithymia Is Associated with Reduced Quality of Life and Increased
\nCaregiver Burden in Parkinson’s Disease. Brain Sci. 2020;10(6):401. Published 2020
\nJun 24.<\/li>\n
\nKrauss JK. Body Concept and Quality of Life in Patients with Idiopathic
\nDystonia. Brain Sci. 2020;10(8):E488. Published 2020 Jul 28. Doi:
\n10.3390\/brainsci10080488<\/li>\n
\nN, Lanfermann H, Ding X. Brain Morphological Alterations Are Detected in Early\u2010
\nStage Parkinson’s Disease with MRI Morphometry. Journal of Neuroimaging. 2020
\nAug 17;2020:231\u20137.<\/li>\n
\nGerbel S, Krause O, Klietz M<\/strong>. Drug safety profiles in geriatric patients with
\nParkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from
\na mono-centric retrospective analysis. J Neural Transm (Vienna). 2021 Jan;128(1):49-
\n60.<\/li>\n
\nMK, Klietz M<\/strong>, Krey LFM, Levin J, Jecmenica-Lukic M, Mac\u00edas-Garc\u00eda D, Meissner
\nWG, Mir P, Morris H, Nilsson C, Rowe JB, Seppi K, Stamelou M, van Swieten JC,
\nWenning G, Del Ser T, Golbe LI, H\u00f6glinger GU; DescribePSP Study Group, the
\nProPSP Study Group, and the Movement Disorder Society-Endorsed PSP Study Group.
\nA Modified Progressive Supranuclear Palsy Rating Scale. Mov Disord. 2021 Jan 29.<\/li>\n
\nYear Trajectory of Caregiver Burden in Parkinson’s Disease and Analysis of GenderSpecific Aspects. Brain Sci. 2021 Feb 26;11(3):295.<\/li>\n
\nH\u00f6glinger GU, Wegner F. Validation of the Parkinson\u2019s Disease Caregiver Burden
\nQuestionnaire in Progressive Supranuclear Palsy. Parkinsons Dis. 2021 May
\n10;2021:9990679. eCollection 2021.<\/li>\n
\nKalmbach N, Klietz M<\/strong>, Hermann A, Lohmann K, Seibler P, Wegner F. Reduced
\nExpression of GABA A Receptor Alpha2 Subunit Is Associated With Disinhibition of
\nDYT-THAP1 Dystonia Patient-Derived Striatal Medium Spiny Neurons. Front Cell
\nDev Biol. 2021 May 21;9:650586. eCollection 2021.<\/li>\n
\nsatisfaction in People with Parkinson\u2019s disease and their caregivers: a cross-sectional
\nobservational study. Brain Sci. 2021 Jun 21;11(6):822.<\/li>\n
\nPiccininni M, Poli S, R\u00f6hrig R, Steinmetz H, Thiele T, Kurth T; German Society of<\/strong>
\nNeurology SARS-CoV-2 Vaccination Study Group<\/strong>. COVID-19 Vaccine-Associated
\nCerebral Venous Thrombosis in Germany. Ann Neurol. 2021 Oct;90(4):627-639. Epub
\n2021 Aug 23.<\/li>\n
\nGU, Lanfermann H and Ding X-Q (2021) Cerebral Microstructural Alterations in
\nPatients With Early Parkinson\u2019s Disease Detected With Quantitative Magnetic
\nResonance Measurements. Front. Aging Neurosci. 13:763331.<\/li>\n
\nof Patients with Parkinson\u2019s Disease into Institutional Care: A Retrospective Pilot
\nStudy. Brain Sci. 2021, 11, 1470.<\/li>\n
\nPatient Safety in a Box: Implementation and Evaluation of the Emergency Box in
\nGeriatric and Parkinson Patients. J Clin Med. 2021 Nov 29;10(23):5618.<\/li>\n
\nGU, Klietz M<\/strong>. Neuropsychiatric Symptoms in Parkinson’s Disease Patients Are
\nAssociated with Reduced Health-Related Quality of Life and Increased Caregiver
\nBurden. Brain Sci. 2022 Jan 11;12(1):89.<\/li>\n
\nGrothe, Joana B. Pereira, G\u00fcnter U H\u00f6glinger. Reduction in volume of nucleus basalis
\nof Meynert is specific to Parkinson\u2019s disease and Progressive supranuclear palsy but
\nnot to Multiple system atrophy. Front. Aging Neurosci., (2022).<\/li>\n<\/ul>\n\n
\nPharmacotherapies for Parkinson\u2019s Disease in Geriatric Patients. Drugs and Aging.
\n2019 Apr 2.<\/li>\n<\/ul>\n\n
\n
\nPhenotypic Traits of Striatal Neurons Expressing Tyrosine Hydroxylase and Effects of
\nNigrostriatal Dopamine Pathway Injury. 7th IBRO Meeting Florence, Italy.<\/li>\n
\nTyrosine hydroxylase-positive interneurons in mouse striatum express both VMAT2
\nand VIAAT and exhibit plasticity for dynorphin. SFN Neuroscience Abstract,
\nWashington, D.C., US.<\/li>\n
\nTyrosine Hydroxylase Positive Neurons are Regulated in a Mouse Model of L-DOPA
\nInduced Dyskinesia 8th FENS Forum of Neuroscience, July 14th-18th, Barcelona, Spain.<\/li>\n
\nExpression analysis of dopaminergic marker genes in tyrosine hydroxylase positive
\nneurons in the striatum of TH-eGFP mice by laser microdissection. Abs. T11-12C,
\nG\u00f6ttingen Meeting of the German Neuroscience Society 2013, G\u00f6ttingen, Germany.<\/li>\n
\ntyrosine hydroxylase-positive neurons trigger L-DOPA-induced dyskinesia in mice.
\nNeurowoche M\u00fcnchen, Germany.<\/li>\n
\nDepboylu (2016). L-DOPA-induced dyskinesia is associated with a deficient numerical
\ndownregulation of striatal tyrosine hydroxylase mRNA-expressing neurons DGN
\nCongress Mannheim, Germany.<\/li>\n
\nVersorgungssituation und Lebensqualit\u00e4t schwer betroffener Parkinsonpatienten unter
\npalliativmedizinischen Aspekten. Deutscher Parkinsonkongress Baden-Baden,
\nGermany.<\/li>\n
\nF. (2017) Quality of life and influencing factors in a local population of advanced
\ngeriatric Parkinson\u00b4s Disease patients. Movement Disorder Society 2017 Vancouver.<\/li>\n
\n(2017). Palliative care and quality of life in a German cohort of geriatric patients with
\nadvanced Parkinson\u00b4s disease. DGN Congress Leipzig, Germany.<\/li>\n
\n(2017). Caregiver burden of relatives from advanced Parkinson\u00b4s disease patients.
\nDGN Congress Leipzig, Germany.<\/li>\n
\n(2018). Whole brain spectroscopy in early Parkinson\u2019s disease: an exploratory MRI
\nstudy. DGN Congress Berlin, Germany.<\/li>\n
\nB, Lange F, Wegner F, Dressler D (2019) Dystonia treated with Botulinum Toxin:
\nQuality of Life and Caregiver Burden. Toxins, Copenhagen, Denmark.<\/li>\n
\nWegner F. (2020). Alexithymia is associated with worse quality of life and caregiver
\nburden in people with Parkinson’s disease. Movement Disorders (virtual Meeting).<\/li>\n
\nKlietz M<\/strong>. (2020). Achtsamkeit und psychologische Flexibilit\u00e4t sind invers mit der
\nsubjektiven Belastung pflegender Angeh\u00f6riger von Patienten mit Morbus Parkinson
\nassoziiert. DGN Kongress, Berlin.<\/li>\n
\nDressler D., H\u00f6glinger G.U., Klietz M<\/strong>. (2020). Assoziation motorischer und kognitiver
\nSymptome mit der gesundheitsbezogenen Lebensqualit\u00e4t von Parkinson-Patienten und
\nder Belastung ihrer betreuenden Angeh\u00f6rigen in einer Kohorte fortgeschrittener
\nParkinson-Patienten. DGN Kongress, Berlin.Symposium<\/strong><\/li>\n
\nBewegungssto\u0308rungen\u201c Deutscher Parkinsonkongress Hannover\/online 2022.<\/li>\n<\/ul>\n